Latest News

All News Media Interview
AI meets antibody design: Galux draws $29M series B for drug R&D
MEDIA
BIOWORLD
February 10, 2026

AI meets antibody design: Galux draws $29M series B for drug R&D

Read More
Galux: Scaling AI-designed biologics
MEDIA
BIOCENTURY
February 10, 2026

Galux: Scaling AI-designed biologics

Read More
For its next AI deal, Boehringer turns to Galux for precision protein design
MEDIA
FIRSTWORD PHARMA
December 18, 2025

For its next AI deal, Boehringer turns to Galux for precision protein design

Read More
Designed by AI: the future of antibody drugs
MEDIA
THE PHARMACEUTICAL JOURNAL
August 22, 2025

Designed by AI: the future of antibody drugs

Read More
Y-Biologics and Galux to co-develop AI-driven immune anticancer treatment
MEDIA
THE BIO
March 13, 2025

Y-Biologics and Galux to co-develop AI-driven immune anticancer treatment

Read More
Galux to conduct joint research with LG Chem on cancer drug development
MEDIA
KOREA JOONGANG DAILY
August 26, 2024

Galux to conduct joint research with LG Chem on cancer drug development

Read More